Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1974 Mar 16;1(5906):472. doi: 10.1136/bmj.1.5906.472

Editorial: The thyroid and breast cancer.

PMCID: PMC1633509  PMID: 4817157

Full text

PDF

Page 472

472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowers C. Y., Friesen H. G., Hwang P., Guyda H. J., Folkers K. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem Biophys Res Commun. 1971 Nov;45(4):1033–1041. doi: 10.1016/0006-291x(71)90441-4. [DOI] [PubMed] [Google Scholar]
  2. Burke C. W., Anderson D. C. Sex-hormone-binding globulin is an oestrogen amplifier. Nature. 1972 Nov 3;240(5375):38–40. doi: 10.1038/240038a0. [DOI] [PubMed] [Google Scholar]
  3. Edwards C. R., Forsyth I. A., Besser G. M. Amenorrhoea, galactorrhoea, and primary hypothyroidism with high circulating levels of prolactin. Br Med J. 1971 Aug;3(5772):462–464. doi: 10.1136/bmj.3.5772.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eskin B. A., Bartuska D. G., Dunn M. R., Jacob G., Dratman M. B. Mammary gland dysplasia in iodine deficiency. Studies in rats. JAMA. 1967 May 22;200(8):691–695. [PubMed] [Google Scholar]
  5. Eskin B. A. Iodine metabolism and breast cancer. Trans N Y Acad Sci. 1970 Dec;32(8):911–947. doi: 10.1111/j.2164-0947.1970.tb02988.x. [DOI] [PubMed] [Google Scholar]
  6. FISHMAN J., HELLMAN L., ZUMOFF B., GALLAGHER T. F. Influence of thyroid hormone on estrogen metabolism in man. J Clin Endocrinol Metab. 1962 Apr;22:389–392. doi: 10.1210/jcem-22-4-389. [DOI] [PubMed] [Google Scholar]
  7. HUMPHREY L. J., SWERDLOW M. THE RELATIONSHIP OF BREAST DISEASE TO THYROID DISEASE. Cancer. 1964 Sep;17:1170–1173. doi: 10.1002/1097-0142(196409)17:9<1170::aid-cncr2820170912>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  8. LYONS A. R., EDELSTYN G. A. THYROID HORMONE AS A PROPHYLACTIC AGENT FOLLOWING RADICAL TREATMENT OF BREAST CANCER. Br J Cancer. 1965 Mar;19:116–121. doi: 10.1038/bjc.1965.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moossa A. R., Evans D. A., Brewer A. C. Thyroid status and breast cancer. Reappraisal of an old relationship. Ann R Coll Surg Engl. 1973 Sep;53(3):178–188. [PMC free article] [PubMed] [Google Scholar]
  10. REPERT R. W. Breast carcinoma study: relation to thyroid disease and diabetes. J Mich State Med Soc. 1952 Oct;51(10):1315–passim. [PubMed] [Google Scholar]
  11. Ruder H., Corvol P., Mahoudeau J. A., Ross G. T., Lipsett M. B. Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab. 1971 Sep;33(3):382–387. doi: 10.1210/jcem-33-3-382. [DOI] [PubMed] [Google Scholar]
  12. SOMMERS S. C. Endocrine abnormalities in women with brest cancer. Lab Invest. 1955 May-Jun;4(3):160–174. [PubMed] [Google Scholar]
  13. STOLL B. A. A clinical trial of tri-iodothyronine as a hormone potentiator in advanced breast cancer. Br J Cancer. 1962 Sep;16:436–440. doi: 10.1038/bjc.1962.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Salih H., Brander W., Flax H., Hobbs J. R. Prolactin dependence in human breast cancers. Lancet. 1972 Nov 25;2(7787):1103–1105. doi: 10.1016/s0140-6736(72)92713-4. [DOI] [PubMed] [Google Scholar]
  15. Schottenfeld D. The relationship of breast cancer to thyroid disease. J Chronic Dis. 1968 Aug;21(5):303–313. doi: 10.1016/0021-9681(68)90039-8. [DOI] [PubMed] [Google Scholar]
  16. Skovsted L., Hansen J. M., Kristensen M., Christensen L. The androsterone-etiocholanolone excretion ratio in hyper- and hypothyroidism. Acta Med Scand. 1966 Sep;180(3):301–306. doi: 10.1111/j.0954-6820.1966.tb02839.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES